v3.26.1
Note 2 - Significant Accounting Policies (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Amortization of above and below Market Leases $ 1,244 $ 1,244 $ 2,487 $ 2,265    
Deferred Costs 1,200,000   1,200,000   $ 1,300,000  
Operating Lease, Initial Direct Cost Expense, over Term 74,516 82,657 157,962 217,433    
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation 5,902,592   5,902,592   7,422,359  
Restricted Cash 4,400,000   4,400,000   5,700,000  
Deferred Offering Costs 322,666   322,666   279,603  
Impairment of Real Estate 144,688 90,769 220,327 117,712    
Marketable Securities 0   0   0  
Liabilities, Fair Value Disclosure 0   0   0  
Equity Securities, FV-NI 11,628   11,628   3,900  
Conduit Pharmaceuticals Inc [Member]            
Equity Securities, FV-NI 11,628   11,628   $ 3,900 $ 206,177
Commercial Property [Member]            
Impairment of Real Estate 3,000,000   3,500,000      
Model Home [Member]            
Impairment of Real Estate   4,300,000   4,300,000    
Finite-lived Intangibles, Other Than Lease Intangibles [Member]            
Intangible Asset, Finite-Lived, Amortization Expense $ 1,540 $ 4,382 $ 3,080 $ 8,763    
Maximum [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year) 5 years   5 years      
Minimum [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year) 1 year   1 year      
Leasehold Improvements [Member] | Maximum [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year) 10 years   10 years